Secondary Myelofibrosis Active Not Recruiting Phase 1 Trials for Fludarabine (DB01073)

IndicationStatusPhase
DBCOND0030964 (Secondary Myelofibrosis)Active Not Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02917096Ruxolitinib Phosphate and Chemotherapy Given Before and After Reduced Intensity Donor Stem Cell Transplant in Treating Patients With MyelofibrosisTreatment